Hepatic arterial infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hepatic arterial infusion, covering 2022-05-05 to 2022-05-05. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) [Phase 2]